Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5575119 | PM&R | 2016 | 11 Pages |
Abstract
Human, culture-expanded AMSCs maintain their viability, proliferative capacity, and metabolic function following passage through needles as small as 30-gauge at constant flow rates of 4 mL/min, despite an early, nonspecific stress/cytoprotective response. These initial findings suggest that culture-expanded AMSCs should tolerate the injection process during most cell-based therapeutic interventions.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Kentaro DO, Dakota L. BS, Scott M. MD, Eric A. PhD, David G. MD, Jacob L. MD, Allan B. PhD, Wenchun MD, PhD, Andre J. PhD, Jay MD,